Alamar Biosciences, a US-based company powering precision proteomics to enable the earliest detection of disease, has an...
Japan-based Taiho Pharmaceutical and Araris Biotech AG, a Swiss biotechnology company developing next-generation antibod...
Novotech, a global leading full-service clinical Contract Research Organization (CRO), and Acrostar, a provider of Site ...
South Korea-based Lunit, a leading provider of artificial intelligence (AI)-powered solutions for cancer diagnostics and...
India-based Cipla has announced an exclusive licensing agreement with Taiwan-based Formosa Pharmaceuticals for the comme...
Australia-based Telix Pharmaceuticals has announced that the Brazilian Health Regulatory Agency (Agencia Nacional d...
ABL Diagnostics, a Euronext-listed leader in molecular diagnostics, has announced an exclusive distribution agreement wi...
Proteomics International Laboratories, a pioneer in precision diagnostics, has announced the launch of its first...
American medtech firm GE HealthCare has announced the launch of the AltiX AI.i edition of Mac-Lab, CardioLab and ComboLa...
Gene Bio Medical (GBM), a leading Canadian biotechnology company specialising in molecular diagnostics, has signed a&nbs...
British pharmaceutical firm AstraZeneca has entered into a definitive agreement to acquire Belgium-based biotech startup...
Teva Hong Kong has announced a strategic partnership with Kerry Pharma, the subsidiary of Kerry Logistics Network (KLN)....
Shimadzu Corporation, a global leader in the precision instrumentation industry, and Diagnostics Development Hub (DxD Hu...
Italy-based Tethis S.p.A., a pioneer in standardised liquid biopsy platform development, and Sheba Medical Center, ...
US-based biotech firm Indaptus Therapeutics, Inc. has secured new patent approvals in China, Japan and Israel for its De...
South Korea-based startup Lunit, a leading provider of artificial intelligence (AI)-powered solutions for cancer diagnos...
The offering includes: €850 million floating rate notes, due March 2027, bearing interest at 3-month Eur...
Japan-headquartered Astellas Pharma Inc. and Yaskawa Electric Corporation have signed a definitive agreement t...
